Skip to main content
ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.770
+0.010 (0.27%)
Apr 28, 2026, 4:00 PM EDT - Market closed

ADC Therapeutics Revenue

In the year 2025, ADC Therapeutics had annual revenue of $81.36M with 14.85% growth. ADC Therapeutics had revenue of $23.06M in the quarter ending December 31, 2025, with 36.36% growth.

Revenue (ttm)
$81.36M
Revenue Growth
+14.85%
P/S Ratio
5.89
Revenue / Employee
$421,539
Employees
193
Market Cap
479.50M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202581.36M10.52M14.85%
Dec 31, 202470.84M1.28M1.84%
Dec 31, 202369.56M-140.35M-66.86%
Dec 31, 2022209.91M175.99M518.89%
Dec 31, 202133.92M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MiMedx Group 418.63M
4D Molecular Therapeutics 85.21M
Fulcrum Therapeutics 80.00M
Verastem 30.91M
Armata Pharmaceuticals 4.90M
Upstream Bio 2.85M
Lyell Immunopharma 36.00K
Revenue Rankings

ADCT News

More News